CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Liuhui Fu, PhD

    CRI Funded Scientist

    Liuhui Fu, PhD

    Liuhui Fu, PhD, is a postdoctoral fellow at the NYU Grossman School of Medicine, where he investigates…
  • Joseph Collins, PhD

    CRI Funded Scientist

    Joseph Collins, PhD

    Joseph Collins, PhD, is a postdoctoral fellow at Boston Children’s Hospital, where he investigates how macrophages regulate…
  • CRI Funded Scientist

    Jesse Boumelha, PhD

    Jesse Boumelha, PhD, is a postdoctoral researcher at the Icahn School of Medicine at Mount Sinai, where…
  • CRI Funded Scientist

    Hannah Bell, PhD

    Hannah Bell, PhD, is a postdoctoral fellow at the University of Michigan, where she investigates novel mechanisms…
  • Seongyeol Park, MD, PhD

    CRI Funded Scientist

    Seongyeol Park, MD, PhD

    Seongyeol Park, MD, PhD, a biomedical scientist trained in both medical and bioinformatics techniques, is tackling the…
  • CRI Funded Scientist

    Liam Hendrikse, PhD

    Dr. Hendrikse is developing a novel immunotherapy aimed at overcoming resistance in blood cancers. His project focuses…
  • CRI Funded Scientist

    Anca Apavaloaei, PhD

    Anca Apavaloaei, PhD is a postdoctoral researcher at Weill Cornell Medicine, where she’s pioneering the development of…
  • CRI Funded Scientist

    Domhnall McHugh, PhD

    Pancreatic cancer is associated with poor prognosis in patients due to therapy resistance and presence of advanced…
  • CRI Funded Scientist

    Maria Sirenko, PhD

    Myelodysplastic syndromes (MDS) are a heterogeneous collection of blood cancers caused by genetic mutations in the blood…
Previous Page
1 … 9 10 11 12 13 … 29
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute